Author Index: K

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Kabiri, M.
• MAKING HEPATITIS C A RARE DISEASE IN THE UNITED STATES: MODEL-BASED PREDICTIONS
Kahn, V. C.
• BOOKLET TALK: PATIENT USE OF DECISION AIDS IN PROSTATE CANCER DIAGNOSIS ENCOUNTERS
• IF YOU BUILD THE FIELDS OF SHARED DECISION MAKING DREAMS, CAN PROSTATE CANCER PATIENTS PLAY?
Kallen, M. A.
• CANCELLED: DOES ANIMATION IMPROVE COMPREHENSION OF RISK INFORMATION IN PATIENTS WITH LOW HEALTH LITERACY?
Kamath, G.
• ATTENTION TO SOCIAL DISADVANTAGE IN CANCER-RELATED PATIENT DECISION AIDS: A CRITICAL REVIEW OF U.S. RANDOMIZED CONTROLLED TRIALS
Kamel, H.
• MODELING THE COST EFFECTIVENESS OF NEUROIMAGING-BASED TREATMENT OF ACUTE STROKE PATIENTS WITH UNKNOWN STROKE ONSET TIME
Kampinga, M.
• META-ANALYSIS OF PREFERENCE-BASED QUALITY OF LIFE VALUES IN CORONARY HEART DISEASE
Kanesvaran, R.
• *TOP RANKED ABSTRACT AT THE 2014 ASIA - PACIFIC CONFERENCE* CONCORDANCE IN PREFERENCES FOR END OF LIFE CARE BETWEEN ADVANCED CANCER PATIENTS AND THEIR CAREGIVERS IN SINGAPORE: A DISCRETE CHOICE EXPERIMENT
Karanam, C.
• THE DELIVERY OF GLOBAL CARDIOVASCULAR RISK BY VIRTUAL HUMANS: EFFECTS ON INTENT TO ADHERE TO LIFESTYLE CHANGE
Karanth, S.
• IMPACT OF INSURANCE STATUS ON OUT-OF-POCKET COST FOR U.S. INDIVIDUALS WITH STROKE
Karnon, J.
• COMPARATIVE EFFECTIVENESS RESEARCH TO INFORM QUALITY IMPROVEMENT USING LINKED COSTS, OUTCOMES, AND PROCESS DATA
Karwan, M.
• ESTIMATING LIPID MANAGEMENT GUIDELINES' RISK VALUE OF A LIFE YEAR ON TREATMENT
Kassner, A.
• USABILITY TESTING OF A PATIENT EDUCATION TOOL FOR VAGINAL BIRTH AFTER CESAREAN (VBAC)
Kattan, M. W.
• VARIABILITY IN REVASCULARIZATION TREATMENT DECISIONS AMONG HOSPITALS AND ITS ASSOCIATION WITH SURGICAL MORTALITY
Katz, P.
• POOR QUALITY OF COMMUNICATION AMONG DIVERSE COHORT OF ADULTS WITH RHEUMATOID ARTHRITIS: RACE/ETHNICITY, LANGUAGE AND FATIGUE ASSOCIATED WITH RATINGS
Katz, S.
• FACTORS ASSOCIATED WITH DECISIONS FOR CONTRALATERAL PROPHYLACTIC MASTECTOMY
Kealey, E.
• USING A WEB-BASED PATIENT REPORTED OUTCOMES TOOL (MYPSYCKES) TO ASSESS MENTAL HEALTH PATIENTS' INTEREST IN ALTERNATIVE THERAPIES AND RELATED CONCERNS
• DEVELOPING AND EVALUATING A WEB-BASED PATIENT REPORTED OUTCOMES AND DECISION SUPPORT TOOL (MYPSYCKES)
• CONSUMER USABILITY TESTING OF A WEB-BASED PATIENT REPORTED OUTCOMES (PROS) AND DECISION SUPPORT TOOL (MYPSYCKES): IMPORTANT LESSONS FOR PROS SYSTEMS
• USING A WEB-BASED PATIENT REPORTED OUTCOMES PROGRAM (MYPSYCKES) TO EXAMINE PATIENT SMOKING STATUS AND INTEREST IN CESSATION SUPPORT
Kee, F.
• HAS MY PATIENT RESPONDED TO TREATMENT? THE SELDOM ASKED QUESTION IN PERSONALIZED MEDICINE RESEARCH
• TRADING OFF BENEFIT AND RISK OF SIDE EFFECTS FOR PERSONALIZED MEDICINE? A CONJOINT ANALYSIS STUDY
Kelly, E.
• RETURN ON INVESTMENT OF A WORK-FAMILY INTERVENTION: EVIDENCE FROM THE WORK, FAMILY, AND HEALTH NETWORK
Kemp, B.
• ESTIMATING THE COSTS ASSOCIATED WITH MENINGOCOCCAL OUTBREAKS IN BRAZIL AND COLOMBIA
Kempf, M. C.
• MODELING DEPRESSION TREATMENT STRATEGIES FOR HUMAN IMMUNODEFICIENCY VIRUS INFECTED (HIV+) PATIENTS USING AGENT-BASED MODELING
Kendzerska, T.
• THE ECONOMIC IMPACT OF CLOSTRIDIUM DIFFICILE: A SYSTEMATIC REVIEW
Kerr, T.
• DYNAMICS IN THE COSTS OF CRIMINALITY AMONG OPIOID DEPENDENT INDIVIDUALS
Kessler, J.
• COST-EFFECTIVENESS OF FIRST LINE LPV/R-BASED REGIMEN FOR HIV INFECTED INFANTS IN WESTERN KENYA
Khalil, G.
• MEASURING CANCER RISK PERCEPTION DURING YOUNG ADULTHOOD: A PERCEIVED TEMPORAL SUSCEPTIBILITY TO CANCER
Khan, F.
• REAL-TIME ESTIMATES OF NET CLINICAL BENEFIT OF ANTITHROMBOTIC THERAPY FOR PATIENTS WITH ATRIAL FIBRILLATION
Khojandi, A.
• MEDICAL DECISION MAKING PROBLEMS WITH LARGE POLICY SPACES: WHY MARKOV DECISION PROCESSES TRUMP SIMULATION
Kil, P. J. M.
• DEVELOPMENT AND USABILITY TESTING OF AN INTERACTIVE WEB-BASED DECISION AID FOR THE TREATMENT OF LOW-AND INTERMEDIATE RISK PROSTATE CANCER
• THE ROLE OF SELF-EFFICACY IN PROSTATE CANCER TREATMENT DECISION MAKING
• DISSATISFACTION WITH INFORMATION PROVISION IS ASSOCIATED WITH WORSE QUALITY OF LIFE AND ILLNESS PERCEPTION AMONG PROSTATE CANCER SURVIVORS: RESULTS FROM THE PROFILES REGISTRY
• DECISIONAL CONFLICT IN PROSTATE CANCER TREATMENT DECISION MAKING: HOW EFFECTIVE IS INFORMATION PROVISION?
Kim, D. D.
• ESTIMATING PREFERENCE WEIGHTS IN OBESITY USING THE EQ-5D AND SF-6D
KIM, I.
• RELATIVE BENEFITS ON HOSPITALIZATION AND AVERTED HOSPITALIZATION COSTS OF LIVE ATTENUATED INFLUENZA VACCINE (LAIV) PREFERENTIAL POLICY FOR CHILDREN, AGES 2-8
Kim, J. J.
• SCREENING HIGH-RISK MEN FOR ANAL CARCINOGENSIS: MODEL DEVELOPMENT AND POLICY ANALYSIS
Kim, J. B.
• AN ITEM RESPONSE THEORY APPROACH FOR PREDICTING THE EQ-5D RESPONSES FROM THE SF-12
Kim, S.
• THE CLINICAL, PSYCHO-SOCIAL AND COST IMPACTS OF PERFORMING ACTIVE SURVEILLANCE ON KNOWN MRSA+ PATIENTS ADMITTED TO MEDICAL-SURGICAL UNITS
Kimmel, A. D.
• STRUCTURAL VALIDATION TO MINIMIZE ERRORS IN SPREADSHEET MODELS
Kirk, R.
• THE CLINICAL, PSYCHO-SOCIAL AND COST IMPACTS OF PERFORMING ACTIVE SURVEILLANCE ON KNOWN MRSA+ PATIENTS ADMITTED TO MEDICAL-SURGICAL UNITS
Kirton, O.
• SIMULATION TRAINING TO IMPROVE CLINICAL DECISION-MAKING BY SURGICAL RESIDENTS
Kissela, B.
• REAL-TIME ESTIMATES OF NET CLINICAL BENEFIT OF ANTITHROMBOTIC THERAPY FOR PATIENTS WITH ATRIAL FIBRILLATION
Kistler, C. E.
• THE CORRELATION BETWEEN THREE MORTALITY INDICES TO DETERMINE THE LIKELIHOOD OF BENEFIT FROM COLORECTAL CANCER SCREENING IN COMMUNITY-DWELLING OLDER ADULTS
• TESTING A COLORECTAL CANCER SCREENING DECISION AID TARGETED TO OLDER ADULTS
• STRENGTH OF EVIDENCE FOR STRATEGIES USED TO DISSEMINATE MEDICAL EVIDENCE TO CLINICIANS AND PATIENTS
• FINDINGS FROM A SYSTEMATIC REVIEW OF ALTERNATE STRATEGIES FOR COMMUNICATING THE UNCERTAINTY OF MEDICAL EVIDENCE
• WHICH COMMUNICATION STRATEGIES IMPACT THE EFFECTIVENESS OF MESSAGES ABOUT MEDICAL EVIDENCE?
Klein, D. E.
• HOW DOES LUNG CANCER SCREENING INFLUENCE PATIENT ATTITUDES ABOUT QUITTING SMOKING? AN EXAMINATION OF PATIENT REACTIONS WHEN SCREENING IS IMPLEMENTED IN PRIMARY CARE
Klein, M.
• USABILITY TESTING OF A PATIENT EDUCATION TOOL FOR VAGINAL BIRTH AFTER CESAREAN (VBAC)
Klein, R.
• ECONOMIC AND CLINICAL IMPACT OF SWITCHING FROM ANTIMUSCARINICS TO MIRABEGRON FOR THE TREATMENT OF OVERACTIVE BLADDER
• A PROGRESSIVE CALIBRATION PROCEDURE FOR INDIVIDUALIZED COLORECTAL CANCER SCREENING STUDY
Klein, T.
• ECONOMIC AND CLINICAL IMPACT OF SWITCHING FROM ANTIMUSCARINICS TO MIRABEGRON FOR THE TREATMENT OF OVERACTIVE BLADDER
Kleindorfer, D.
• REAL-TIME ESTIMATES OF NET CLINICAL BENEFIT OF ANTITHROMBOTIC THERAPY FOR PATIENTS WITH ATRIAL FIBRILLATION
Kline, J.
• CLINICAL DECISION RULES UBIQUITOUS TO THE EMERGENCY CARE SETTING ARE NOT EFFECTIVE IN RESOLVING THE BURDEN OF UNNECESSARY CT IMAGING IN WOMEN EVALUATED FOR PULMONARY EMBOLISM
Klocker, H.
• THE ONCOTYROL PROSTATE CANCER OUTCOME AND POLICY MODEL - LESSONS LEARNED FROM NATURAL HISTORY CALIBRATION
Kluibenschaedl, M.
• COST-EFFECTIVENESS OF THE SEQUENTIAL APPLICATION OF TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CHRONIC MYELOID LEUKEMIA PATIENTS IN THE UNITED STATES
Knight, S. J.
• INSIGHTS FROM FUNDING AGENCIES
Knudsen, A.
• OPTIMAL COLORECTAL CANCER SCREENING FOR A HIGHER-RISK POPULATION: THE CASE OF NORTHEASTERN PENNSYLVANIA
Kohn, M. A.
• ADVANCED EVIDENCE-BASED DIAGNOSIS (ROC CURVES, INTERVAL LIKELIHOOD RATIOS, AND BIAS IN TEST ACCURACY STUDIES)
Koliba, C.
• A SYSTEM DYNAMICS APPROACH TO OPTIMIZING RESOURCE ALLOCATION IN KIDNEY DIALYSIS VERSUS TRANSPLANTATION
Kone, V.
• DETECTING MEDULLARY THYROID CANCER AMONG ADULT PATIENTS WITH THYROID NODULE: IS THERE A BEST STRATEGY? A COST-EFFECTIVENESS ANALYSIS
Kong, N.
• USING SIMULATION MODELING TO COMPARE ALTERNATIVE LIFESTYLE APPROACHES AND PREVENT CARDIOVASCULAR DISEASE
• A PROGRESSIVE CALIBRATION PROCEDURE FOR INDIVIDUALIZED COLORECTAL CANCER SCREENING STUDY
Konings, I. C. A. W.
• EXPLORING THE EFFECTS OF FACTORS ASSOCIATED WITH THE OUTCOME OF PANCREATIC CANCER SCREENING IN HIGH-RISK INDIVIDUALS BY THE USE OF A MICROSIMULATION MODEL
Korbin, S.
• INSIGHTS FROM FUNDING AGENCIES
Koru-Sengul, T.
• ETHNIC, GENDER, AND MARITAL STATUS DISPARITIES OF THE BURDEN OF CANCER-ATTRIBUTABLE INFECTIONS IN THE US: NHANES (1999-2012)
• BURDEN OF CANCER-ATTRIBUTABLE INFECTIONS IN THE US: ANALYSIS FROM NATIONAL POPULATION-BASED SURVEYS (1999-2012)
• A CULTURALLY-TAILORED BROCHURE TO IMPROVE UNDERSTANDING AMONG WOMEN WITH AN INCOMPLETE MAMMOGRAM RESULT
Koyapathodi, N.
• USE OF INNOVATIVE, REAL-TIME VOICE ANALYTICS TO GUIDE CLINICIANS' TELEPHONIC INTERACTIONS WITH INDIVIDUALS IN CLINICAL PROGRAMS
Krabbe, P.
• MULTINATIONAL COMPARISON OF VALUES FOR THE 5-LEVEL EQ-5D BASED ON VISUAL ANALOGUE SCALE AND DISCRETE CHOICE MODELING
Krabbe, P.
• META-ANALYSIS OF PREFERENCE-BASED QUALITY OF LIFE VALUES IN CORONARY HEART DISEASE
Krahn, M.
• PRESIDENTIAL ADDRESS
• Meet the SMDM-HTA Fellows
Krahn, M. D.
• THE IMPACT OF ESTIMATING MORTALITY RATES IN COST-EFFECTIVENESS ANALYSIS.: A SIMULATION STUDY
• COST-EFFECTIVENESS ANALYSIS OF PALLIATIVE TEAM CARE FOR PATIENTS NEARING END-OF-LIFE
• THE ONCOTYROL PROSTATE CANCER OUTCOME AND POLICY MODEL - LESSONS LEARNED FROM NATURAL HISTORY CALIBRATION
• COST-EFFECTIVENESS OF SCREENING HEPATITIS C IN CANADA
• COST-EFFECTIVENESS OF HEPATITIS B VIRUS SCREENING BEFORE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH EARLY STAGE BREAST CANCER
• THE ECONOMIC IMPACT OF CLOSTRIDIUM DIFFICILE: A SYSTEMATIC REVIEW
• WOUND INTERDISCIPLINARY TEAMS (WIT): A COMMUNITY-BASED PRAGMATIC RANDOMIZED CONTROLLED TRIAL
• IMPLEMENTATION CHALLENGES OF A COMMUNITY-BASED PRAGMATIC RANDOMIZED CONTROLLED TRIAL IN WOUND CARE
• ADOPTING THE PHASE-OF-CARE APPROACH TO ESTIMATE COSTS OF A SECONDARY DIAGNOSIS OF CLOSTRIDIUM DIFFICILE
• COST EFFECTIVENESS ANALYSIS OF SYSTEMATIC REFERRAL TO MULTIDISCIPLINARY WOUND CARE TEAMS IN ONTARIO. EVIDENCE FROM THE WOUND INTERDISCIPLINARY TEAMS (WIT) TRIAL
• ESTIMATING HEALTHCARE COSTS FOR DECISION-ANALYTIC MODELS IN ATRIAL FIBRILLATION USING ADMINISTRATIVE DATA
• COMPLEX INTERVENTIONS FOR COMPARATIVE EFFECTIVENESS AND HEALTH TECHNOLOGY ASSESSMENT
Krebs, E.
• DYNAMICS IN THE COSTS OF CRIMINALITY AMONG OPIOID DEPENDENT INDIVIDUALS
Kreyenbuhl, J.
• EFFECTIVENESS OF COMPUTERIZED WEIGHT MANAGEMENT WITH PEER SUPPORTS FOR PEOPLE WITH MENTAL ILLNESS
Krishnamurthy, D.
• THE DELIVERY OF GLOBAL CARDIOVASCULAR RISK BY VIRTUAL HUMANS: EFFECTS ON INTENT TO ADHERE TO LIFESTYLE CHANGE
Kristiansen, I. S.
• COSTS AND OUTCOMES OF FIVE SURGICAL TREATMENTS FOR GREAT SAPHENOUS VARICOSE VEINS: HIGH LIGATION AND STRIPPING, LASER ABLATION, RADIOFREQUENCY ABLATION, STEAM VEIN SCLEROSIS AND CYANOACRYLATE GLUE
• CALCIUM AND VITAMIN D FOR HIP FRACTURE PREVENTION IN LIGHT OF POSSIBLE CARDIOVASCULAR SIDE EFFECTS
• SCREENING HIGH-RISK MEN FOR ANAL CARCINOGENSIS: MODEL DEVELOPMENT AND POLICY ANALYSIS
• THE IMPACT OF INFORMATION ABOUT CERVICAL CANCER SCREENING'S SIDE EFFECTS ON INTENTION TO BE SCREENED: A RANDOMIZED SURVEY-BASED STUDY OF NORWEGIAN AND AMERICAN WOMEN
Kristoffersen, A. E.
• CONTINUITY OF THE DOCTOR-PATIENT RELATIONSHIP MAY INFLUENCE DECISIONS TO SEE A COMPLEMENTARY AND ALTERNATIVE MEDICAL CARE PROVIDER
Kroep, J. R.
• PARTNERING OR PERSUADING: DECISION MAKING DURING CONSULTATIONS BETWEEN BREAST CANCER PATIENTS AND MEDICAL ONCOLOGISTS
Kroep, S.
• EXPLORING THE EFFECTS OF FACTORS ASSOCIATED WITH THE OUTCOME OF PANCREATIC CANCER SCREENING IN HIGH-RISK INDIVIDUALS BY THE USE OF A MICROSIMULATION MODEL
• OPTIMIZING PARAMETERS FOR SCREENING MODELS: A REVIEW AND COMPARISON OF DIFFERENT GOODNESS OF FIT CRITERIA
• OPTIMIZING PARAMETERS FOR SCREENING MODELS: A COMPARISON OF DIFFERENT PARAMETER SEARCH ALGORITHMS
Kruk, M.
• TASK-SHARING OR PUBLIC FINANCE FOR THE EXPANSION OF SURGICAL ACCESS IN RURAL ETHIOPIA: AN EXTENDED COST-EFFECTIVENESS ANALYSIS
Kuehne, F.
• WHEN IS ENOUGH EVIDENCE ENOUGH? VALUE-OF-INFORMATION ANALYSIS FOR PRIORITIZING ADDITIONAL OUTCOMES RESEARCH ON THE TREATMENT OF CHRONIC MYELOID LEUKEMIA
Kues, J.
• REAL-TIME ESTIMATES OF NET CLINICAL BENEFIT OF ANTITHROMBOTIC THERAPY FOR PATIENTS WITH ATRIAL FIBRILLATION
Kulasingam, S.
• HETEROGENEITY IN MARKOV MODELS OF THE NATURAL HISTORY OF DISEASE: INVESTIGATING ONCOGENICITY
Kulikowski, C.
• ESTIMATING THE IMPACT OF PNEUMOCOCCAL CONJUGATE VACCINES IN RESOURCE-POOR SETTINGS: A PORTABLE HEALTH POLICY MODEL FOR NEW VACCINE INTRODUCTION
Kullgren, J.
• DEVELOPMENT OF A MEDICAL MAXIMIZER SCALE
Kumar, A.
• UNCERTAINTY ABOUT EFFECTS IS A KEY FACTOR INFLUENCING INSTITUTIONAL REVIEW BOARDS' APPROVAL OF CLINICAL STUDIES
Kumar, S.
• COMPARATIVE AND COST-EFFECTIVENESS ANALYSES OF LABORATORY-BASED AND NON-LABORATORY-BASED CARDIOVASCULAR RISK SCREENING IN UZBEKISTAN
Kunneman, M.
• REASON FOR ENCOUNTER: A MISSED OPPORTUNITY FOR SHARED DECISION MAKING
Kuntz, K. M.
• OPTIMAL COLORECTAL CANCER SCREENING FOR A HIGHER-RISK POPULATION: THE CASE OF NORTHEASTERN PENNSYLVANIA
• HETEROGENEITY IN MARKOV MODELS OF THE NATURAL HISTORY OF DISEASE: INVESTIGATING ONCOGENICITY
• CALIBRATION OF PIECEWISE MARKOV MODELS USING A BAYESIAN CHANGE-POINT ANALYSIS THROUGH AN ITERATIVE CONVEX OPTIMIZATION ALGORITHM
• POTENTIAL BIAS ASSOCIATED WITH MODELING THE EFFECTIVENESS OF TREATMENT USING AN OVERALL HAZARD RATIO
• RISK STRATIFICATION USING CSF BIOMARKERS IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT-AN EXPLORATORY ANALYSIS
• USING BIOMARKER TESTING TO TARGET TREATMENT TO PATIENTS WITH MILD COGNITIVE IMPAIRMENT AT INCREASED RISK OF ALZHEIMER'S DISEASE
• SHINGLES VACCINE FOR RHEUMATOID ARTHRITIS PATIENTS: SHOULD WE GIVE IT A SHOT?
Kuo, K. L.
• COST-EFFECTIVENESS OF THE SEQUENTIAL APPLICATION OF TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CHRONIC MYELOID LEUKEMIA PATIENTS IN THE UNITED STATES
Kurt, M.
• ELICITING LIPID MANAGEMENT GUIDELINES' VALUATION OF FUTURE LIFE
• ESTIMATING LIPID MANAGEMENT GUIDELINES' RISK VALUE OF A LIFE YEAR ON TREATMENT
Kurzthaler, C.
• WHEN IS ENOUGH EVIDENCE ENOUGH? VALUE-OF-INFORMATION ANALYSIS FOR PRIORITIZING ADDITIONAL OUTCOMES RESEARCH ON THE TREATMENT OF CHRONIC MYELOID LEUKEMIA
• THE ONCOTYROL PROSTATE CANCER OUTCOME AND POLICY MODEL - LESSONS LEARNED FROM NATURAL HISTORY CALIBRATION
• *TOP RANKED ABSTRACT AT THE 15TH BIENNIAL EUROPEAN MEETING* COMBINING MARKOV STATES: A COMPARISON OF ANALYTICAL AND HEURISTIC METHODS FOR DERIVING THE HAZARD RATES OF A COLLAPSED MARKOV STATE
Kwong, J.
• ESTIMATING THE HEALTHCARE COSTS ATTRIBUTABLE TO INVASIVE MENINGOCOCCAL DISEASE
• THE ECONOMIC IMPACT OF CLOSTRIDIUM DIFFICILE: A SYSTEMATIC REVIEW
• ADOPTING THE PHASE-OF-CARE APPROACH TO ESTIMATE COSTS OF A SECONDARY DIAGNOSIS OF CLOSTRIDIUM DIFFICILE
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z